0.70 USD
214.05 M USD
1.02 B USD
About BAVARIAN NORDIC A/S
Sector
CEO
Paul Chaplin
Headquarters
Hellerup
Website
Founded
1992
FIGI
BBG004MKB1Q9
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Displays a symbol's price movements over previous years to identify recurring trends.